Preclinical Research
Effect of Housing on Stress-Related Parameters in NHPs
Detection of Peripheral Blood Foxp3+ Regulatory T Cell Population in a Preclinical Setting
Translatability of Non-Human Primate Cytokine Data to In-Life Parameters in Nonclinical
A Multi-Peptide Hybrid LC-MS/MS Assay for the Determination of CTI-1601 in Monkey Tissues Provides Insight into its Disposition and Processing
Assessing an animal welfare program
When choosing an outsourcing partner for your nonclinical studies, it is imperative to evaluate the strength of a contract research organization's animal welfare program. Since animal welfare is the cornerstone for achieving high quality scientific results, understanding the components of a successful program can guide you in your assessment. |
Frequently asked SEND questions & Pro tips
Navigating the SEND requirements can be complicated. By asking the right questions upfront, you'll be able to choose a knowledgeable and experienced partner who can guide you through the process, help you avoid potential delays and prepare reliable SEND datasets for FDA submissions. Before you choose your SEND partner, read our frequently asked questions and quick pro tips. |
Integrating Anatomic and Clinical Pathology into reports
Anatomic and Clinical Pathology datasets are critical when evaluating the safety and efficacy of a drug during the preclinical stage of drug development. Since anatomic and clinical pathology identify and characterize toxicity by different, yet complementary means, integrating both datasets provides a more comprehensive assessment for predicting important toxicities that could occur in humans. Successful integration requires that anatomic and clinical pathologists collaborate closely. At least one of them must also understand the utility and limitations of both disciplines. |
To ensure seamless integration of pathology data into the overall study report, our teams work closely with one another and follows established workflows and communication systems for every project. Additionally, our team can offer guidance on how to best use an integrated assessment for making critical decisions related to your drug candidate. And, since one of our team members is a dual-certified Anatomic and Clinical Pathologist who brings over 25 years of drug development knowledge to Altasciences, you'll have a trusted partner available to guide you. To learn more about how we can support you, speak to an expert. |
Visit Our Preclinical Facility
Visit Our Preclinical Facility Evaluating the safety and efficacy of your molecule requires partnering with a trusted Contract Research Organization (CRO). With over 25 years of experience conducting safety assessment studies in both large and small molecules, the Altasciences team has the expertise you need to provide high-quality safety data for your regulatory submissions. Located just north of Seattle, our preclinical facility is convenient to travel to in order to conduct a capabilities overview or quality audit, or for study monitoring. With the recent opening of the Paine Field Airport, getting here has never been easier. The new airport services 9 destination cities and is less than 3 miles from our facility.
Schedule a visit, we would be happy to provide a tour. |
Preclinical Case Study - Assessing the Safety of Novel Therapeutics for Pediatric Indications